Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Medtronic
Boehringer Ingelheim
Moodys
Baxter
McKinsey
Mallinckrodt

Last Updated: January 22, 2020

DrugPatentWatch Database Preview

TICAR Drug Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

When do Ticar patents expire, and when can generic versions of Ticar launch?

Ticar is a drug marketed by Glaxosmithkline and is included in two NDAs.

The generic ingredient in TICAR is ticarcillin disodium. There are five drug master file entries for this compound. Additional details are available on the ticarcillin disodium profile page.

Summary for TICAR
Drug patent expirations by year for TICAR
Synonyms for TICAR
(2S,5R,6R)-6-[[(2R)-3-hydroxy-3-oxo-2-(3-thienyl)propanoyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-6-[[(2R)-CARBOXY-3-THIENYLACETYL]AMINO]-3,3-DIMETHYL-7-OXO-4-THIA-1-AZABICYCLO[3.2.0]HEPTANE-2-CARBOXYLIC ACID DISODIUM SALT
29457-07-6
29457-07-6,34787-01-4(freebase)
34807-28-8
4697-14-7
74682-62-5
A822398
A827122
AC1LAKYM
Aerugipen
AKOS027276160
API0004413
BIT0186
BRL 2288
BRL-2288
C-22212
C14021
CAS-4697-14-7
CC-35060
CHEBI:35017
CHEMBL1200855
D02241
Disodium (2S-(2alpha,5alpha,6beta(S*)))-6-(carboxylato-3-thienylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate
disodium (2S,5R,6R)-3,3-dimethyl-6-[[(2R)-3-oxidanidyl-3-oxidanylidene-2-thiophen-3-yl-propanoyl]amino]-7-oxidanylidene-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
disodium (2S,5R,6R)-3,3-dimethyl-6-[[(2R)-3-oxido-3-oxo-2-thiophen-3-ylpropanoyl]amino]-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
disodium (2S,5R,6R)-6-[[(2R)-2-carboxylato-1-oxo-2-(3-thiophenyl)ethyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
disodium (2S,5R,6R)-6-{[(2R)-2-carboxylato-2-thiophen-3-ylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
disodium 6beta-{[(2R)-2-carboxylato-2-thiophen-3-ylacetyl]amino}-2,2-dimethylpenam-3alpha-carboxylate
Disodium Ticarcillin
DSSTox_CID_25561
DSSTox_GSID_45561
DSSTox_RID_80958
EINECS 249-642-5
G8TVV6DSYG
HMS1571E16
MolPort-003-959-756
Monapen
N-(2-Carboxy-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)hept-6-yl)-3-thiophenemalonamic acid disodium salt
NCGC00017046-01
SCHEMBL41224
sodium (2S,5R,6R)-6-((R)-2-carboxylato-2-(thiophen-3-yl)acetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
Ticar (TN)
TICARCILLIN DISODIUM
Ticarcillin disodium (USP)
Ticarcillin disodium salt
Ticarcillin Disodium Salt (Contain 10% Methanol)
Ticarcillin disodium salt, >=95%
ticarcillin sodium
Ticarcillin sodium (JAN)
Ticarpen
Tox21_110756
UNII-G8TVV6DSYG
ZX-AFC000251

US Patents and Regulatory Information for TICAR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline TICAR ticarcillin disodium INJECTABLE;INJECTION 050497-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Glaxosmithkline TICAR ticarcillin disodium INJECTABLE;INJECTION 050497-003 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Glaxosmithkline TICAR ticarcillin disodium INJECTABLE;INJECTION 062690-001 Dec 19, 1986 DISCN No No   Start Trial   Start Trial   Start Trial
Glaxosmithkline TICAR ticarcillin disodium INJECTABLE;INJECTION 050497-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Glaxosmithkline TICAR ticarcillin disodium INJECTABLE;INJECTION 050497-005 Apr 4, 1984 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Merck
Dow
Express Scripts
McKesson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.